Solu-Medrol   body {font-family: 'Open Sans', sans-serif;} .ui-header .ui-title, .ui-footer .ui-title { margin-right: 0 !important; margin-left: 0 !important; } \* { margin:0px; padding:0px;} .ui-page { background: #f2f2f2 url(bg.jpg); line-height:1.5em;} #home\_link { color:#FFF; text-decoration:none; cursor:pointer; font-family:'AndikaBasicRegular',Arial, sans-serif; font-size:0.9em; margin-left:15%; } #home\_link span {font-size:0.6em;margin-left:15%; color: #D8D8D8; } h1 {font-family:'AndikaBasicRegular'; }

# Solu-Medrol

**Solu-Medrol (Methylprednisilone)**  
Medrol, Duralone, Medralone, M-Prednisol, and Solu-Medrol are all trade names for generic drug Methylprednisolone.  
Not as popular in anesthesia as Decadron or Solu-Cortef  
**Class:** Glucocorticoid  
5x more potent than hydrocortisone.  
Minimal mineralcorticoid activity  
**Common Anesthesia Related Indications: (like other glucocorticoids)**  
Anti-inflammatory  
Treat or prevent allergic reactions.  
Status asthmaticus  
To treat nausea and vomiting associated with some chemotherapy drugs.  
Replace steroids in conditions of a supressed HPA axis.  
**Doses:** 40-60mg IV q6h  
**Spinal Cord Injury:** 30mg/kg IV over 15 minutes followed with 5.4mg/kg/h x 23 or 47 hours  
**High Dose:** 30 mg/kg **administered intravenously over at least 30 minutes**. This dose may be repeated every 4 to 6 hours for 48 hours.  
Peds: 0.16-0.8mg/kg/day  
Peds :Refractory Status Asthmaticus -1-2 mg/kg/day in single or divided doses.  
Also recommended that short course, or "burst" therapy, be continued until the patient achieves a peak expiratory flow rate of 80% of his or her personal best or until symptoms resolve.  
**Exacerbation of Multiple Sclerosis: PO**\- 160 mg of methylprednisolone for a week followed by 64 mg every other day for 1 month.  
**Excretion:** nearly complete within 12 hours.  
**Adverse Effects**  
Arrhythmias and /or Cardiac Arrest from Large doses > 0.5grams given over less than < 10 minutes has been reported.  
Bradycardia- unrelated to speed of infusion.  
**Warning**  
Anticholinesterases: Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. If possible, anticholinesterase agents should be withdrawn at least 24 hours before initiating corticosteroid therapy.  
Anticoagulants, oral: Coadministration of corticosteroids and warfarin usually results in inhibition of response to warfarin, although there have been some conflicting reports. Therefore, coagulation indices should be monitored frequently to maintain the desired anticoagulant effect.

#### Copyright Â© 2012